Gene Discovery Points to New Pathways and Treatment Strategy for Amyotrophic Lateral Sclerosis (ALS), Study Funded by CVS/pharmacy and ALS Therapy Alliance Reveals
Published: Aug 27, 2012
NEEDHAM, Mass.--(BUSINESS WIRE)--In the battle to find a cure for amyotrophic lateral sclerosis (ALS), scientists from Belgium have made a rare and exciting discovery: a new gene that influences survival time of ALS. The findings, reported in today’s issue of Nature Medicine, were funded in part by CVS/pharmacy and the ALS Therapy Alliance, a Boston-based nonprofit. The findings also confirm another recent study that identified the same pathway to finding a treatment for ALS.